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In Vivo Dehydroepiandrosterone Restores Age-Associated
Defects in the Protein Kinase C Signal Transduction Pathway
and Related Functional Responses
Emanuela Corsini,1* Laura Lucchi,* Massimo Meroni,* Marco Racchi,† Bruno Solerte,‡
Marisa Fioravanti,‡ Barbara Viviani,* Marina Marinovich,* Stefano Govoni,† and
Corrado L. Galli*
Elderly subjects are at increased risk of pneumonia, influenza, and tuberculosis. Besides the known age-related decrease in
mechanisms for mechanical clearance of the lungs, impaired alveolar macrophage function contributes to the increased risk of
illness in the elderly. We have previously shown that age-induced macrophage immunodeficiencies are associated with a defective
system for anchoring protein kinase C. Castration of young male rats produces effects on alveolar macrophages similar to those
of aging, suggesting a relationship between circulating sex hormones, particularly androgens, and the decreases in the receptor for
activated C kinase (RACK-1) and macrophage function observed. The aging process in humans and rats is associated with a
decline in the plasma concentrations of dehydroepiandrosterone (DHEA) and its sulfate, among other steroid hormones. We report
here that in vitro and in vivo administration of DHEA to rats restores the age-decreased level of RACK-1 and the LPS-stimulated
production of TNF- in alveolar macrophages. DHEA in vivo also restores age-decreased spleen mitogenic responses and the level
of RACK-1 expression. These findings suggest that the age-related loss in immunological responses, linked to defective pathways
of signal transduction, are partially under hormonal control and can be restored by appropriate replacement therapy. The
Journal of Immunology, 2002, 168: 1753–1758.
T he aging immune system is less able to cope with infec-tious disease than earlier in life, with increased morbidityand mortality among the elderly (1, 2). Many factors con-
tribute to immunosenescence including stem cell defects, thymus
involution, aging of resting immune cells, replicative senescence
of clonally expanding cells, defects in APC, and dysfunction in
several signal transduction pathways (3, 4). Age-related alterations
in the functional capacity of macrophages are likely to contribute
significantly to the increased risk of illness in the elderly (5), be-
cause these cells directly affect natural immunity. The aging pro-
cess depresses chemotaxis and phagocytosis (3), induces a defi-
cient respiratory burst (4), and is associated with a decline in the
ability of these cells to present Ags and to produce cytokines
(6–10).
Alveolar macrophages (AM)2 are resident airway cells, situated
at the air-tissue interface in the alveoli and alveolar ducts, which
are primarily responsible for the protection of the lungs against
inhaled toxins, bacteria, viruses, parasites, and particles. It has re-
cently been shown (11) that aging is associated with a significant
decrease in accessory cell function and the release of TNF- from
human AM stimulated by LPS.
We have recently demonstrated (12) that the age-associated de-
cline in macrophage function reflects an impaired protein kinase C
(PKC) signal transduction pathway and in particular is correlated
with a defective PKC-anchoring system. PKC is a family of phos-
pholipid-dependent serine-threonine kinases involved in the signal
transduction of hormones, neurotransmitters, and cytokines (13).
Furthermore, we demonstrated in AM that many key mediators of
the host response to infections, namely, hydrogen peroxide pro-
duction, lysozyme release, and TNF- production, are indeed de-
pendent on PKC activation (14). Activation of PKC results in re-
distribution (translocation) of the enzyme from the cytosol to
membrane compartments (13). A family of proteins that interact
with PKC (for a review, see Ref. 15), which are receptors for
activated C kinase (RACKs), are 30- to 36-kDa proteins located in
various subcellular compartments. RACK-1, a 36-kDa protein
cloned from rat brain, is the best characterized member of the
RACK family; it preferentially interacts with PKC-. We have
shown that a deficit in RACK-1, in the absence of differences in
the expression of LPS receptor or total PKC isoforms, contributes
to the functional impairment in aged AM (12). In particular, the
use of RACK-1 antisense oligonucleotide reduces the ability of
macrophages to respond to LPS, indicating the importance of this
protein in macrophage activation (12).
The mechanism is unclear. An attractive hypothesis is that an
age-associated change in the neuroendocrine system may affect
macrophages. Aging is associated with several alterations in hor-
mone production, secretion, and action. In particular, dehydroepi-
androsterone (DHEA) and its sulfate (DHEA-S), the most abun-
dantly secreted adrenal steroids, are known to increase throughout
childhood and puberty and then to decrease in old age. The average
serum DHEA concentration in men 25–34 years old is 15.9  6.1
nM, but this value falls to 5.4  1.7 nM in those age 75–85 years
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(16). Reduced secretion of DHEA during aging has been related to
a series of age-associated conditions, including atherosclerosis and
cardiovascular disease, breast cancer, obesity, loss of muscle mass,
and diabetes, and there is a view that supplementation with DHEA
may have a number of significant clinical uses (17). Immunocom-
petence also declines with age (17, 18). We therefore investigated
the role of DHEA in age-associated immunological dysfunction
and in particular the effect of this hormone on RACK-1 expression
and PKC-dependent functions in AM.
Materials and Methods
Animals
Young (3–4 mo) and old (19 mo) Sprague Dawley male rats were pur-
chased from Charles River (Calco, Italy), as were sham-operated and or-
chiectomized young rats. Sham operated rats are rats anesthetized, incised,
and sewed up but not orchiectomized. All animal care procedures were in
accordance with the Guidelines for Care and Use of Experimental Animals.
Chemicals
Steroid hormones, flutamide, and LPS from Escherichia coli were obtained
from Sigma (St. Louis, MO), Con A from Boehringer (Mannheim, Ger-
many), recombinant murine TNF- from R&D Systems (Minneapolis,
MN), Abs against murine CD14 and PKC-II from Santa Cruz Biotech-
nology (Santa Cruz, CA), anti-rat RACK-1 from Transduction Laborato-
ries (Affinity, Nottingham, U.K.), and anti-murine -actin from Sigma.
Electrophoresis reagents were from Bio-Rad (Richmond, CA).
Experimental procedures
For in vivo treatment with DHEA, rats were randomly assigned to the
following groups (n  5): 1) old rats given implants of vehicle (propylene
glycol) alone; 2) old rats given DHEA (2.5 mg/kg) implants; and 3) young
rats without implants. Alzet 2MLM2 osmotic minipumps (Alza, Palo Alto,
CA) were implanted s.c. on the backs of the animals. DHEA in propylene
glycol was delivered at 2 mg/day during 2 wk. In preliminary experiments,
no significant differences in the parameters measured were noted in pro-
pylene glycol-treated and untreated rats.
Assay for DHEA-S
Circulating DHEA-S was determined by a commercially available RIA
(Coat-A-count; DPC, Los Angeles, CA) for which the limit of detection
was 0.11 ng/ml.
Cells
AM were collected by bronchoalveolar lavage as described previously
(19). Recovery was 10–15  106 cells/animal, of which 98% were mac-
rophages (Giemsa stain). Once washed and resuspended to 106 viable AM/
ml, for functional assays cells were allowed to adhere to plastic plates in
RPMI 1640 (Sigma) containing 2 mM L-glutamine, 0.1 mg/ml streptomy-
cin, 100 IU/ml penicillin, and 50 ng/ml gentamicin (medium) for 1 h at
37°C in 5% CO2. For TNF- release 0.3–0.5  106 cells were plated in
24-well plates, whereas for Western blot analysis 4–5  106 cells were
plated in 60-mm petri dishes. Cells were then exposed to medium with 10%
FCS (Sigma) and incubated with or without LPS in the presence or absence
of steroid hormones, or DMSO as vehicle control. In all experiments in-
volving the in vitro use of hormones, RPMI without phenol red and char-
coal-stripped calf serum were used.
In vitro lymphocyte proliferation assay
Spleens were aseptically removed and homogenized, and cells were resus-
pended at a concentration of 2  106 viable cells per ml of medium.
Cultures were set up in triplicate with 0.1 ml cells and 0.1 ml medium alone
or with LPS 5 g/ml and Con A 2 g/ml. Cell cultures were incubated for
72 h, pulsed during the last 18 h with 1 Ci/well [3H]thymidine (Amer-
sham, Little Chalfont, U.K.), and harvested using a cell harvester (Dyna-
tech; PBI, Milan, Italy). The uptake of [3H]thymidine was measured in a
scintillation counter (Packard, Meriden, CT). Results are expressed as a
stimulation index, i.e., cpm in mitogen-stimulated cells/cpm in cells treated
with medium alone.
Assay for TNF
TNF content was assayed by determining the cytotoxicity of TNF against
sensitive L929 cells, as previously described (20). The results are ex-
pressed in picograms per milliliter. TNF concentration was calculated
against a standard curve with known amounts of recombinant murine TNF.
Western blot analysis
For CD14, PKC-II, RACK-1, and -actin,4–10 106 cells were lysed
in homogenization buffer (50 mM Tris, 150 mM NaCl, 5 mM EDTA (pH
7.5), 0.5% Triton X-100, 50 M PMSF, 2 g/ml aprotinin, 1 g/ml pep-
statin, and 1 g/ml leupeptin) and denatured for 10 min at 100°C (21). The
protein content of the cell lysate was measured using a commercial kit
(Bio-Rad). The cell proteins (10 g) were electrophoresed into a 12%
SDS-polyacrylamide gel under reducing conditions. The proteins were then
transferred to PVDF membrane (Amersham). The different proteins were
visualized using a CD14 antiserum (1/200), RACK-1 (1/2500), PCK-II
(1/5000) and -actin (1/5000) as the primary Abs and developed using
ECL (Amersham). The immunoblotting image was acquired with a Nikon
CCD video camera module. The OD of the bands was calculated and an-
alyzed by means of the Image 1.47 program for digital image processing
(W. Rasband, Research Service Branch, National Institute of Mental
Health, National Institutes of Health, Bethesda, MD).
In vitro PKC-II translocation assay
AM (5  106) obtained from young and old rats were treated for 24 h in
the presence or absence of DHEA (1 nM) or DMSO as vehicle control in
medium with 10% FCS in 15-ml polypropylene tubes. Then, LPS, 100
ng/ml, was added, after five min AM were recovered by centrifugation for
5 min at 1200 rpm at 4°C. The pellets were resuspended in 500 l ho-
mogenization buffer (see Western blot analysis) without Triton X-100 us-
ing a Teflon/glass potter. Cytosolic fractions were separated by centrifu-
gation at 100,000 g for 60 min. The pellets were resuspended in the same
volume of homogenization buffer by sonication at 2 15 s; this constituted
the membrane fractions.
Statistical analysis
All experiments were performed at least twice; representative results are
shown. Statistical significance was determined by Dunnett’s multiple com-
parison test, after ANOVA.
Results
Diminished TNF- production from LPS-stimulated AM from
male castrated rats
AM were obtained by bronchoalveolar lavage from sham operated
and castrated male Sprague Dawley rats. Rats were orchiectomized
at 8 wk of age and were compared with sham operated rats 8 wk
after operation. The samples, consisting of 98% macrophages,
were tested for TNF- production in response to increasing con-
centrations of LPS (0–100 ng/ml). Castration was associated with
a drastic (60%) reduction in TNF- release after 24 h incubation
at all concentrations of LPS tested (Fig. 1a).
We then explored the possibility that this diminished capacity of
AM from castrated rats to produce TNF- might be due to de-
creased levels of LPS receptor (CD14) or a defect in the activation.
In particular, we focused our attention on RACK-1 expression
given that we previously demonstrated that RACK-1 plays an im-
portant role in LPS-induced TNF- release in AM (12). As shown
in Fig. 1b, the diminished production of TNF- by AM of cas-
trated rats can be explained by a reduction in RACK-1 expression,
whereas there was no difference in CD14 or PKC-II expression
(Fig. 1b). -Actin immunoreactivity reveals that equivalent
amounts of proteins have been loaded onto gels (Fig. 1b). The 60%
lower RACK-1 expression in castrated rats (densitometric analysis
of immunoreactivity showed 1465  441 vs 4050  470 U for
sham operated; mean  SD of four independent samples; p 
0.01) corresponds to the reduction in TNF- release after LPS stim-
ulation, which suggests a role for androgen in immunosenescence.
DHEA and DHEA-S restore age-associated decrease in RACK-1
level in vitro
It has been shown that following castration in the rats, plasma
levels of testosterone and DHEA become undetectable (22). To






















test the hypothesis that the hormonal change in the cell environ-
ment associated with aging might be responsible for the loss in
RACK-1 expression and macrophage function, AM obtained from
old rats were treated in vitro for 24 h with a physiologically rel-
evant concentration (1 nM) of DHEA, and with equimolar con-
centrations of DHEA-S, testosterone, and 2-estradiol or with
DMSO as vehicle control () and RACK-1 expression was com-
pared with that from young rats by Western blot analysis. DHEA
and its sulfate to a large extent restored the levels of RACK-1 to
those of young animals, whereas testosterone treatment brought
about only a slight not statistically significant increase and 2-
estradiol caused no increase (Fig. 2a). Under the same experimen-
FIGURE 1. Diminished TNF- production
and RACK-1 expression in AM obtained from
castrated male rats. a. TNF- release after LPS
stimulation. AM produced from sham operated
vs castrated rats: 5,908  1,025 vs 423  142
pg/ml TNF- at 1 ng/ml LPS; 6,331 862 vs
1713  404 at 10 ng/ml; and 11,606  3,166
vs 5,026  695 at 100 ng/ml. Each value rep-
resents the mean  SD of three to four inde-
pendent samples. , p 0.01 vs sham operated
AM, Dunnett’s t test. b, Representative West-
ern blot analysis of RACK-1, PKC-II, CD14
and, as control for protein loading, -actin im-
munoreactivity in AM obtained from sham op-
erated (S.O.) and castrated (cast.) rats.
FIGURE 2. DHEA restores in vitro age-associated
decline in RACK-1 expression, LPS-induced PKC
translocation, and LPS-stimulated TNF- release. a,
Representative Western blot analysis of RACK-1 im-
munoreactivity. Differences in RACK-1 expression
from old AM-treated rats for 24 h with 1 nM concen-
trations of different hormones were calculated by den-
sitometric analysis and expressed as percent of young
AM. Each value represents the mean  SD of three
independent experiments. -Actin was used as control
for protein loading. b, Representative Western blot
analysis of PKC-II translocation in old and young
AM after 24 h treatment with DHEA (1 nM) and 5 min
LPS (100 ng/ml) treatment. -Actin was used as con-
trol for protein loading. c, TNF- release. AM were
treated for 24 h with increasing concentrations of
DHEA (0–10 nM), and then LPS (100 ng/ml) was
added for 24 h. Each value represents the mean  SD
of three to four independent determinations. , p 
0.05 vs old AM treated with LPS; §, p  0.01 vs
young and old  DHEA AM treated with LPS, Dun-
nett’s t test. Inset, Representative Western blot anal-
ysis of RACK-1 immunoreactivity after 24 h treat-
ment with increasing concentrations of DHEA.






















tal conditions, no changes in PKC-II expression were found (data
not shown). Furthermore, DHEA (1 nM) restored both the
age-associated deficit in PKC translocation and in a dose-
dependent manner TNF- production after LPS (100 ng/ml) stim-
ulation (Fig. 2, b and c), which paralleled a dose-dependent
increase in RACK-1 expression (Fig. 2c, inset). With flutamide, an
androgen receptor antagonist (23), DHEA-induced RACK-1 ex-
pression was blocked, indicating that this hormone functions
through the androgen receptor (Fig. 3).
DHEA restores age-associated decrease in RACK-1 level and
LPS-induced TNF- production in vivo
The in vitro evidence of the ability of DHEA to oppose the age-
associated decrease in RACK-1 expression and TNF- production
led us to investigate its ability to restore RACK-1 expression and
macrophage functions in vivo. We implanted ALZET 2ML2 os-
motic pumps s.c. in 21-month-old male Sprague Dawley rats. We
used osmotic pumps to reduce animal handling and stress and to
maintain constant plasma DHEA concentration, and the s.c. route
was chosen because it has been reported (24) to allow 100% bio-
availability. DHEA (2.5 mg/kg) was delivered at a rate of 2 mg/
day during 2 wk, the control group receiving propylene glycol as
vehicle control. Animals were killed 2 wk after implantation, AM
were obtained by bronchoalveolar lavage, and RACK-1 expression
and TNF- production in response to LPS at 24 h were compared
with the values obtained from 3-mo-old rats.
The plasma concentrations of DHEA-S, as a stable marker of
circulating DHEA, are shown in Table I, showing that 21-mo-old
rats had only about one-half the plasma DHEA-S of 3-mo-old rats,
but DHEA administration increased this significantly. Further-
more, the plasma concentrations of DHEA-S reached after delivery
indicates that the dose of 2.5 mg/kg is a pharmacological dose. Fig.
4 shows that AM from the old rats produced at least 50% less
TNF- than AM from young rats at all concentrations of LPS
tested, confirming our previous results (12); the 2-wk treatment
with DHEA restored the ability of old AM to produce TNF- in
response to LPS (Fig. 4a), and this recovery was associated with a
corresponding increase in the level of RACK-1 as assessed by
Western blot analysis and relative densitometric analysis (Fig. 4b).
DHEA partially restores age-associated decline in splenocyte
proliferation
In an investigation of systemic immunity, we evaluated the pro-
liferative response to mitogens in splenocytes obtained from young
rats, old rats, and from old rats treated with DHEA. Old rats
FIGURE 3. Flutamide blocks DHEA-induced RACK-1 expression. AM
obtained from old rats were treated for 1 h with flutamide (10 M) or
DMSO as vehicle control, and then DHEA (1 nM) was added for 24 h.
Representative Western blot analysis of RACK-1 immunoreactivity. The
histogram shows the quantification of RACK-1 immunoreactivity by den-
sitometric analysis. Each value represents the mean  SD of three inde-
pendent experiments. , p  0.01 vs all other groups; §, p  0.01 vs
DHEA-treated AM, Dunnett’s t test. -Actin was used as control for pro-
tein loading.
FIGURE 4. In vivo administration of DHEA to rats restores the age-associated decline in TNF- production and RACK-1 expression by AM. a, TNF-
release. Each value is the mean  SD of four to five independent samples. , p  0.01 vs AM from old vehicle-treated rats; §, p  0.01 vs young AM
and DHEA-treated old AM, Dunnett’s t test. b, Representative Western blot analysis of RACK-1 immunoreactivity in homogenates from AM of old rats
treated with vehicle () or with DHEA () and of young rats, with percent of reactivity relative to young level below. -Actin was used as control for
protein loading. The histogram shows the quantification of RACK-1 immunoreactivity by densitometric analysis. Each value represents the mean  SD
of five animals. , p  0.01 vs AM vehicle-treated old rats; §, p  0.01 vs young AM and AM from DHEA-treated old rats, Dunnett’s t test.
Table I. Plasma level of DHEA-Sa
Group DHEA-S (ng/ml)
Young (3 mo) 24.78  3.91
Old (21 mo) 13.78  4.90§
Old  DHEA, 2.5 mg/kg 123.06 62.53*
a Each value represents the mean  SD of four to five animals. , p  0.01 vs
young group; §, p  0.01 vs young and old plus DHEA groups.






















showed a significantly lower mitogenic response to LPS and Con
A, which DHEA treatment significantly increased (Table II). At
the molecular level, the spleen cell homogenates from older rats
again showed 69  21% (mean  SD of three independent sam-
ples; p  0.01) decrease in RACK-1 immunoreactivity, whereas
DHEA restored these levels to young values (Fig. 5).
Discussion
These results elucidate the mechanism by which the naturally oc-
curring adrenal steroid hormone DHEA corrects age-related dys-
functions in rat alveolar macrophages, with implications for the
role of this hormone in immunosenescence. Age-related immuno-
logical changes result in part from a decrease in the functional
capacity of macrophages. We have shown recently that the age-
associated decline in macrophage functions reflects a defective
PKC signal transduction pathway that specifically affects the abil-
ity of PKC to translocate to the physiological anchoring sites (12).
We demonstrate here the role of DHEA in the age-associated de-
crease in RACK-1 expression and macrophage function and the
ability of DHEA supplementation to boost immunological function
in the aging rat.
Castration of young rats produces effects on AM similar to those
of aging. Castration was associated with decreased expression of
RACK-1 and release of TNF- in response to LPS stimulation
despite there being no differences in CD14, the LPS receptor, or in
total PKC-II expression, which suggested a relationship between
circulating sex hormones, particularly androgens, and the de-
creases in RACK-1 and macrophage function observed. It has been
demonstrated that after castration in the rats the plasma concen-
trations of both testosterone and DHEA become undetectable (22),
indicating a possible role of these hormones in age-associated de-
crease in RACK-1 expression and PKC-dependent functions.
The aging process in humans and rats is associated with a de-
cline in the plasma concentrations of DHEA and its sulfate, among
other steroid hormones. In old male Sprague Dawley rats, we
found 50% lower DHEA-S levels, a stable marker of circulating
DHEA, than in young ones. Using a physiological concentration of
DHEA, which in the young adult rat is 0.3 ng/ml (equivalent to 1
nM), we were able to restore age-associated decreases in RACK-1
expression, LPS-induced PKC translocation, and AM functions in
vitro. We tested other steroid hormones at equimolar concentra-
tions and found that whereas DHEA-S, and testosterone to a lesser
extent, stimulated RACK-1 expression in vitro, 2-estradiol was
ineffective. The latter result is in agreement with data (not shown)
we obtained in ovariectomized rats, where no change in RACK-1
expression in AM was observed, which suggests that estrogens are
not involved in maintaining RACK-1 expression.
Although a receptor for DHEA in both monocytes (25) and T
cells (26) has been described, the physiological effects of DHEA
are probably brought about by its derivatives. With the use of
flutamide, an androgen receptor antagonist, DHEA-induced
RACK-1 expression was prevented, suggesting that DHEA acts
through the androgen receptor.
The observed association between DHEA/DHEA-S and macro-
phage function gives further support to the positive role of these
steroids in the normal functioning of the immune system. The abil-
ity of DHEA to potentiate LPS-induced TNF- production is con-
sistent with data obtained using LPS-stimulated human monocytes
(27). DHEA increased the monocyte response to LPS, whereas
dihydrotestosterone and 17-estradiol did not, indicating the spec-
ificity of DHEA.
In vivo, using a pharmacological dose of DHEA in old rats that
restored the plasma DHEA-S concentration to that in young rats,
we also restored the levels of RACK-1 expression, of LPS-induced
TNF- production by AM, and of LPS-induced splenocyte prolif-
eration. Our results confirm the immunostimulatory properties of
DHEA (reviewed in Refs. 18 and 28) and, more importantly, high-
light its mechanism of action: DHEA restores the age-associated
impairment in PKC signal transduction by increasing RACK-1 ex-
pression, which is essential for PKC translocation, thus restoring
PKC-dependent functions, such as B and T lymphocyte prolifer-
ation, respiratory burst, phagocytosis, etc. (12, 29–33).
At present, we are not able to establish whether DHEA or its
metabolites increase directly the transcription of RACK-1 through
interaction with the androgen receptor or by interacting with other
downstream transcription factors. To our knowledge, the sequence
of the promoter region of RACK-1 is not available. Furthermore,
specific DHEA-responsive elements have yet to be described.
Overall, the present findings are consistent with the possibility
that age-related loss in functional responses linked to signal trans-
duction-defective pathways may be at least partially under hor-
monal control and restored by appropriate replacement therapy.
Our results further support the concept that DHEA serves impor-
tant regulatory functions. By its ability to restore RACK-1 expres-
sion and PKC functional impairment, supplementation of DHEA
may be beneficial for such factors as hormones, neurotransmitters,
and cytokines; those require correctly functional PKC machinery
for their physiological activities.
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